Article
Rapid and Specific Screening Assay for KRAS Oncogene Mutation by a Novel Gene Amplification Method.
Anticancer research - 1 Apr 2016
Kumasaka Akira, Matsumoto Naoyuki, Mukae Shotaro, Kitano Taiichi, Noguchi Hiroyasu, Ohki Hidero, Komiyama Kazuo, Ando Tomohiro
Abstract excerpt
BACKGROUND: Epidermal growth factor receptor (EGFR) is a target of molecular therapeutics for colorectal cancer. However, mutation of Kirsten rat sarcoma viral oncogene homolog (KRAS) gene at codons 12 and 13 attenuates the therapeutic effect of anti-EGFR therapies. Therefore, the detection of KRAS gene mutation is important for therapeutic decision-making. MATERIALS AND METHODS: KRAS gene mutation at codons 12...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
